Adverum Biotechnologies News

Strong Phase 2 Results and Favorable Safety Profile Justify Buy Rating for Adverum Biotechnologies

TipRanksJul 22 08:17 ET

Adverum Biotechnologies Analyst Ratings

BenzingaJul 18 17:08 ET

Adverum Biotechnologies (ADVM) Receives a Buy From Truist Financial

TipRanksJul 15 07:17 ET

Adverum Biotechnologies Analyst Ratings

BenzingaJun 25 08:34 ET

Strong Buy Rating for Adverum Biotechnologies Amid Anticipated Positive Phase 2 Results and Market Undervaluation

TipRanksMay 16 04:50 ET

Adverum Biotechnologies Analyst Ratings

BenzingaMay 15 14:22 ET

Adverum Biotechnologies Analyst Ratings

BenzingaMay 10 08:37 ET

Adverum Biotechnologies Analyst Ratings

BenzingaApr 30 06:11 ET

Adverum Biotechnologies Analyst Ratings

BenzingaApr 29 07:36 ET

Analysts Are Neutral on These Healthcare Stocks: SAGE Therapeutics (SAGE), Adverum Biotechnologies (ADVM)

TipRanksMar 27 21:55 ET

Adverum Biotechnologies Analyst Ratings

BenzingaMar 19 12:02 ET

Chardan Capital Reiterates Buy on Adverum Biotechnologies, Maintains $4 Price Target

BenzingaMar 19 08:56 ET

Adverum Biotechnologies Analyst Ratings

BenzingaMar 19 08:14 ET

RBC Capital Maintains Sector Perform on Adverum Biotechnologies, Lowers Price Target to $2

BenzingaMar 19 08:14 ET

RBC Cuts Price Target on Adverum Biotechnologies to $2 From $3, Keeps Sector Perform, Speculative Risk

MT NewswiresMar 19 07:12 ET

Adverum Biotechnologies (ADVM) Initiated With a Hold at RBC Capital

TipRanksMar 19 06:50 ET

Adverum Biotechnologies (ADVM) Receives a Buy From TD Cowen

TipRanksMar 18 18:01 ET

Adverum Biotechnologies Analyst Ratings

BenzingaFeb 6 14:15 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Healthequity (HQY), Adverum Biotechnologies (ADVM) and Edwards Lifesciences (EW)

TipRanksFeb 5 04:50 ET

Analysts Offer Insights on Healthcare Companies: InMode (INMD), Ocular Therapeutix (OCUL) and Adverum Biotechnologies (ADVM)

TipRanksDec 11, 2023 02:20 ET